BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 3011246)

  • 1. Immunoconjugate generation between the ribosome inactivating protein restrictocin and an anti-human breast carcinoma MAB.
    Orlandi R; Canevari S; Conde FP; Leoni F; Mezzanzanica D; Ripamonti M; Colnaghi MI
    Cancer Immunol Immunother; 1988; 26(2):114-20. PubMed ID: 3258791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmenting the Efficacy of Immunotoxins and Other Targeted Protein Toxins by Endosomal Escape Enhancers.
    Fuchs H; Weng A; Gilabert-Oriol R
    Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27376327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.
    Gilabert-Oriol R; Weng A; Mallinckrodt Bv; Melzig MF; Fuchs H; Thakur M
    Curr Pharm Des; 2014; 20(42):6584-643. PubMed ID: 25341935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the increased cytotoxicity of gelonin anti-T cell immunoconjugates compared with ricin A chain immunoconjugates.
    Fishwild DM; Wu HM; Carroll SF; Bernhard SL
    Clin Exp Immunol; 1994 Jul; 97(1):10-8. PubMed ID: 8033405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete suppression of in vivo growth of human leukemia cells by specific immunotoxins: nude mouse models.
    Hara H; Seon BK
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3390-4. PubMed ID: 3494997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date.
    Sandström EG; Kaplan JC
    Drugs; 1987 Sep; 34(3):372-90. PubMed ID: 2824170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroviruses and malignant lymphoma.
    Norley SG; Kurth R
    Blut; 1989 May; 58(5):221-7. PubMed ID: 2541838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotoxins: new therapeutic reagents for autoimmunity, cancer, and AIDS.
    Vitetta ES
    J Clin Immunol; 1990 Nov; 10(6 Suppl):15S-18S. PubMed ID: 2081785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of a weakly active ricin A chain immunotoxin recognizing the neural cell adhesion molecule.
    Derbyshire EJ; Stahel RA; Wawrzynczak EJ
    Clin Exp Immunol; 1992 Sep; 89(3):336-40. PubMed ID: 1325302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 receptor expression in the haematologic malignancies: a target for immunotherapy.
    Waldmann TA
    Cancer Surv; 1989; 8(4):891-903. PubMed ID: 2701734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human interleukin-2 receptor.
    Greene WC; Leonard WJ
    Annu Rev Immunol; 1986; 4():69-95. PubMed ID: 3011033
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective killing of human T-lymphotropic virus-I infected leukemic T-cells by monoclonal anti-interleukin 2 receptor antibody-ricin A chain conjugates: potentiation by ammonium chloride and monensin.
    Krönke M; Schlick E; Waldmann TA; Vitetta ES; Greene WC
    Cancer Res; 1986 Jul; 46(7):3295-8. PubMed ID: 3011246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
    Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
    Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 2 receptor (Tac antigen) expression in HTLV-I-associated adult T-cell leukemia.
    Waldmann TA; Longo DL; Leonard WJ; Depper JM; Thompson CB; Krönke M; Goldman CK; Sharrow S; Bongiovanni K; Greene WC
    Cancer Res; 1985 Sep; 45(9 Suppl):4559s-4562s. PubMed ID: 2990687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
    Waldmann TA; Leonard WJ; Depper JM; Krönke M; Goldman CK; Oh T; Greene WC
    Princess Takamatsu Symp; 1984; 15():259-68. PubMed ID: 6100644
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.